Nurse Practitioner position in Pediatric Solid Tumor (10 hrs/week)
This job is no longer active.
View similar jobs.
POST DATE 7/2/2020
END DATE 7/11/2020
Dana-Farber Cancer Institute
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
In collaboration with a physician, the NP/PA will manage therapeutic and supportive regimens for acute and chronic problems associated with such disease, treatment and/or conditions. The NP/PA in this position will be working with pediatric oncology patients focusing within the disease group of solid tumors. The NP/PA provides anticipatory guidance, patient and family education, and psychological and emotional support. The NP/PA has prescriptive authority which includes schedule II through V controlled substances in the Commonwealth of Massachusetts.
The NP/PA is an integral member of an interdisciplinary care team, partnering with physicians and other team members. This requires effective communication and collaboration with solid tumor team members, with co-workers at the Institute, as well as collaborating institutions and agencies. The role requires critical thinking, an understanding of research principles and practices and leadership that improves the quality of care and advances nursing/medical care within the work setting and throughout the community. The NP/PA takes advantage of formal and informal learning opportunities to strengthen his or her knowledge base in support of the Institute s Mission, Vision and Core Values.
* Delivers expert, scientifically based care to patients using advanced skills in the evaluation, diagnosis and treatment of patients with hematological-oncological diseases and adverse health conditions.
* Assesses patient and family needs from a holistic viewpoint.
* Performs comprehensive physical assessment. Differentiates between normal and abnormal physical findings, and interprets to determine the severity of illness. Recognizes and differentiates oncological emergencies associated with specific diseases and conditions.
* Assesses pain and symptom management that includes side effects of chemotherapy and radiation therapy.
* Formulates a multidisciplinary plan of care based on identified diagnoses. Continually reassesses plan based on patient's current condition.
* Incorporates age-specific interventions related to safety, nutrition, physical limitations, polypharmacy, skin integrity, psychosocial needs and other areas as appropriate in the care provided.
* Administers chemotherapy, medications and treatments in accordance with Institute policy and performs procedures as determined by disease center needs.
* Documents care reflective of advanced practice, and complies with all Institute, collaborating institution and regulatory agency requirements.
* Provides patient and family education, instruction and reinforcement to meet identified learningneeds.
* Identifies appropriate community resources to provide continuity of care and makes appropriate referrals to homecare and hospice agencies.
* Delegates responsibilities for the performance of selected patient care activities to assistive personnel within established regulations and policies. Provides appropriate and intermittent supervision.
* Adheres to the Code of Ethics for Nurses with Interpretive Statements (ANA, 2001) in all aspects of professional practice.
* Recognizes and responds to emergency situations appropriately. Maintains BLS certification.
* Pursues active membership of local and national professional organizations.
* Manages therapeutic regimes and appropriate follow-up care for acute and chronic problems associated with hematological-oncological diseases and conditions.
* Prescribes medications, which may include chemotherapy, IV fluid, and blood component therapy in accordance with research protocols, Medical Staff Bylaws, Institute, state and federal regulations, and collaborating institution policies.
* Evaluates the patient's response to therapy and appropriately modifies interventions as needed.
* Orders consultations, diagnostic and laboratory tests and scans in accordance with research protocols and current practice standards. Completes all requisitions in accordance with DFCI policies and procedures.
* Demonstrates awareness of protocols available in the disease center. Complies with clinical protocol requirements regarding appropriate collection and recording of data and information required.
* Performs diagnostic and therapeutic procedures in accordance with practice guidelines, research protocols, Medical staff Bylaws, Institute and collaborating institution policies.
* Coordinates elective and emergency admissions to collaborating institutions in accordance with the patient's medical condition, research protocols, Medical Staff Bylaws, Institute and collaborating institutions' policies and procedures.
* Obtains required consents for treatment and procedures.
* Practices according to written guidelines in compliance with the Massachusetts Board of Registration in Nursing. Maintains prescriptive privileges as defined by the Massachusetts Department of Public Health. Utilizes prescriptive authority responsibly for Schedule II through V controlled substances in the Commonwealth of Massachusetts.
* Develops and maintains current practice guidelines that specifically describe the nature and scope of the nurse's practice; the circumstances in which physician consultation or referral is required; the use of established procedures for the treatment of common medical conditions which the nurse may encounter; and provisions for managing emergencies. Guidelines must also include a mechanism to monitor prescribing practices including documentation of review with a supervising physician at least every three months; protocols for the initiation of intravenous therapies and Schedule II drugs; specify the frequency of review of initial prescription of controlled substances. The initial prescription of Schedule II drugs must be reviewed within 96 hours.
* Monitors prescriptive practice in collaboration with the supervising physician and submits quarterly reports to direct supervisor.
* Maintains current Collaborative Practice Agreement signed by NP and supervising physician.
* Establishes rapport with patients and families from a variety of cultural, ethnic and religious backgrounds.
* Interacts with patients and families in a caring and compassionate manner.
* Provides patient and family education related to the disease process, treatment plan, alternatives, symptom management, care and follow up.
* Provides care based on the age-specific needs of the patient.
* Fosters an environment that is sensitive to the needs of diverse populations, including but not limited to culture, ethnicity, gender, and age.
* Manages the environment for patient care providing leadership in the identification and integration of resources to achieve desired outcomes.
* Monitors the environment of care with attention to patient safety, and assures compliance with regulatory agency standards.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.